- Joined
- May 24, 2009
- Messages
- 4,673
- Reaction score
- 10,725
- Points
- 7,901
- Attending Physician
You have a good two days so I would suggest going through the WBC disorders and Lymph Node disorders in RR path if you have it. Goljan really does a great job breaking things down into categories and has excellent tables to supplement the text.
I've got a big exam on Monday and we just "learned" today about all the Leukemias and Lymphomas and it's a HUGE jumbled mess in my brain. Does anyone have any good suggestions on how to sort this all out pretty quickly?!
Thanks.
This is what my outline looked like:
White Cell Disorders
-Nonneoplastic- things like leukomoid reaction etc.
-Neoplastic/Neoplasms- leukemias and lymphomas under this one with all of the following under this category:
Lymphoid Neoplasms-Precursor B and T Cell Lymphoblastic
-Burkitt's
- and all of the other lymphoid neoplasms like the plasma cell proliferations and others (with each one do a short description of what's involved - the cell type etc)
Myeloid Neoplasms (Then under the Myeloid Neoplasms all of the following:
Acute Myelogenous Leukemia (you can list all of the subsets and their characteristics)
Chronic Myeloproliferative Disorders
-Chronic Myelogenous Leukemias
-Polycythemia Vera (this doesn't go with the leukemias and lymphomas but it's a chronic myeloid Dysplastic Disorder
-Myelodysplastic Dysplastic Syndromes - this one isn't a leukemia but it's a chronic myeloid dysplastic disorder
At my school, this seriies of lectures was presented Myeloid versus Lymphoid neoplastic disorders with the leukemias and lymphomas discussed under their various categories.
Then, when we used BRS Pathology as a summary of this stuff, we could use our outline and we knew where everything would fit. Overall, the key to this stuff is to organize it and know were each entity fits in the scheme of things and which cells are involved. BRS is good for showing the photos with the outlines but we still had to do some organization as above.
Actually, once you get everything organized, you have done have of the learning. Good luck.
Thanks everyone so far. I did a lot of the stuff last night and this morning and I'm starting to get a grasp on it.
One thing that kind of concerns me (for the boards, not for this exam) is that we covered the Leukemias and the Lymphomas in two 1-hour lectures, with no mention anywhere in the note set/lecture of things like polycythemia and various other things I came across while reading Rapid Review Path. I feel like there's probably a ton of things out there in general that I just won't have learned this year when it comes time to study for Step I later this year.
Thanks everyone so far. I did a lot of the stuff last night and this morning and I'm starting to get a grasp on it.
One thing that kind of concerns me (for the boards, not for this exam) is that we covered the Leukemias and the Lymphomas in two 1-hour lectures, with no mention anywhere in the note set/lecture of things like polycythemia and various other things I came across while reading Rapid Review Path. I feel like there's probably a ton of things out there in general that I just won't have learned this year when it comes time to study for Step I later this year.
Two 1 hr lectures?? Are you taking path? Or is this for an immunology course?
lymphoma - only in lymph nodes, no bone marrow involvement (if bone marrow is involved -> leukemia)
Thanks everyone so far. I did a lot of the stuff last night and this morning and I'm starting to get a grasp on it.
One thing that kind of concerns me (for the boards, not for this exam) is that we covered the Leukemias and the Lymphomas in two 1-hour lectures, with no mention anywhere in the note set/lecture of things like polycythemia and various other things I came across while reading Rapid Review Path. I feel like there's probably a ton of things out there in general that I just won't have learned this year when it comes time to study for Step I later this year.
Small point of clarification. Lymphoma can indeed have bone marrow involvement; this finding comprises the majority of patients with Ann Arbor Stage IV lymphoma.